Results 91 to 100 of about 139,558 (270)

Trends in prevalence of anaemia among people living with HIV in the UK: 20 cross‐sectional analyses using population‐based electronic primary healthcare records

open access: yesHIV Medicine, EarlyView.
Abstract Background People living with HIV have a greater prevalence of anaemia compared with people without HIV, which increases the risk of associated morbidity and premature mortality. Risk factors for anaemia among people living with HIV have changed in recent decades due to new antiretroviral therapy (ART), increased uptake of ART and increasing ...
George B. Freer   +4 more
wiley   +1 more source

Quantifying Residual HIV-1 Replication in Patients Receiving Combination Antiretroviral Therapy [PDF]

open access: bronze, 1999
Linqi Zhang   +17 more
openalex   +1 more source

“They didn't think we'd live this long”: A qualitative exploration of older adults living with HIV perspectives on geriatric care in Ontario

open access: yesHIV Medicine, EarlyView.
Abstract Introduction Advances in human immunodeficiency virus (HIV) care have increased life expectancy, leading to more older adults living with HIV. This study examines older adults' perspectives on geriatric healthcare needs. Methods A community‐based qualitative study in Ontario, Canada, recruited some adults aged 50+ years living with HIV through
Kristina M. Kokorelias   +17 more
wiley   +1 more source

Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa.

open access: yesPLoS ONE, 2015
ObjectiveLimited data are available from the developing world on antiretroviral drug resistance in HIV-1 infected children failing protease inhibitor-based antiretroviral therapy, especially in the context of a high tuberculosis burden.
Theresa M Rossouw   +6 more
doaj   +1 more source

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy [PDF]

open access: bronze, 1999
Manohar R. Furtado   +7 more
openalex   +1 more source

Metabolic syndrome and Pathobiological Determination of Atherosclerosis in Youth risk score in adolescents with and without perinatally acquired HIV in the Cape Town Adolescent and Antiretroviral Cohort (CTAAC)‐Heart study

open access: yesHIV Medicine, EarlyView.
Abstract Background Limited data exist describing metabolic syndrome (MetS) and Pathobiological Determinants of Atherosclerosis in Youth (PDAY) coronary arteries (CA) and abdominal aorta (AA) risk scores in youth with HIV in sub‐Saharan Africa.
Sahera Dirajlal‐Fargo   +14 more
wiley   +1 more source

A case of argyria as consequence of alternative medical treatment

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Murat Cavdar   +5 more
wiley   +1 more source

Comparison of treatment‐emergent resistance‐associated mutations and discontinuation due to adverse events among integrase strand transfer inhibitor‐based single‐tablet regimens and cabotegravir + rilpivirine for the treatment of virologically suppressed people with HIV: A systematic literature review and network meta‐analysis

open access: yesHIV Medicine, EarlyView.
Abstract Objective This study evaluated rates of treatment‐emergent resistance‐associated mutations (TE‐RAMs) and discontinuation due to adverse events (DC‐AEs) across integrase strand transfer inhibitor (INSTI)‐based single‐tablet regimens and injectable cabotegravir + rilpivirine (CAB + RPV) in virologically suppressed people with HIV.
Ishfaq Rashid   +12 more
wiley   +1 more source

Dyslipidemia in HIV-infected individuals

open access: yesBrazilian Journal of Infectious Diseases, 2010
Metabolic complications continue to play a major role in the management of HIV infection. Dyslipidemia associated with HIV infection and with the use of combined antiretroviral therapy includes elevations in triglycerides, reduced high-density ...
Eduardo Sprinz   +3 more
doaj  

Functional T Cell Reconstitution and Human Immunodeficiency Virus–1–Specific Cell‐Mediated Immunity during Highly Active Antiretroviral Therapy [PDF]

open access: green, 1999
Oscar Pontesilli   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy